Cite
HARVARD Citation
Jain, P. et al. (n.d.). Early experience of maintenance durvalumab post chemoradiation (CRT) in stage III non-small cell lung cancer (NSCLC) across West Yorkshire network: from Expanded Access Programme (EAP) to routine clinical use. Lung cancer. pp. S46-. [Online].